Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JANUARY 08, 2014 FBO #4428
SOURCES SOUGHT

Q -- Vascular Access

Notice Date
1/6/2014
 
Notice Type
Sources Sought
 
NAICS
621511 — Medical Laboratories
 
Contracting Office
Department of the Air Force, Air Force Installation Contracting (AFICA), Air Force Installation Contracting (AFICA), 1940 Allbrook Dr, Bldg 1, Door 1, Room 300, Cubicle 481, Wright Patterson AFB, Ohio, 45433-5344, United States
 
ZIP Code
45433-5344
 
Solicitation Number
AFICA_AFMESA-14-RFI-VASCULAR_ACCESS
 
Archive Date
2/20/2014
 
Point of Contact
Ashley Fredlock, Phone: 301-619-8600
 
E-Mail Address
AFMSA.SG5T.Market@us.af.mil
(AFMSA.SG5T.Market@us.af.mil)
 
Small Business Set-Aside
N/A
 
Description
THIS IS NOT A REQUEST FOR PROPOSALS OR A REQUEST FOR QUOTATIONS; IT IS STRICTLY A REQUEST FOR INFORMATION (RFI). NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT. 1. SUBJECT: The Air Force Medical Evaluation Support Activity (AFMESA) is conducting market research on products to assist in obtaining vascular access in an expeditionary medical setting. Responses are due to this request for information (RFI) by 2:00 (EST) on 5 February 2014. 2. DISCLAIMER: This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI marked as "proprietary" will be handled accordingly. Information provided as a response to the RFI will not be returned. AFMESA will not entertain any questions concerning the composition, requirements, or the nature of services to be performed under any future request for proposal (RFP). 3. BACKGROUND: Critically ill and injured patients are often associated with difficult or non-viable intravenous (IV) access. The ability to quickly establish vascular access is essential for the delivery of medications and for fluid replacement, including crystalloids, blood, and blood products. The Air Combat Command Surgeon's Medical Modernization Division (ACC/SGR) is currently interested in ALL devices that will assist in the rapid identification of viable vascular regions and ALL devices that will assist in achieving rapid vascular access. AFMESA is not currently collecting information on standard IV catheters, IV connectors, or standard IV tubing. ACC prefers commercial off-the-shelf (COTS) items but will accept information on government off-the-shelf (GOTS) and foreign off-the-shelf (FOTS) products as well as research and development (R&D) options. 4. REQUIREMENTS: The product(s) sought must operate in an austere environment with the ability to easily and safely transition with the patient throughout the continuum of care. Responses should address the requirements identified in this RFI, particularly those outlined in 4A below. 4A. MANDATORY REQUIREMENTS: Device will assist in the rapid identification of viable vascular regions AND/OR assist in achieving rapid vascular access 5. RESPONSE INFORMATION: Response to this RFI must be submitted to Ms. Ashley A. Fredlock, Market Research Analyst, via e-mail to AFMSA.SG5T.Market@us.af.mil. Email responses should be no larger than 10 MB in size. If larger attachments are required, please notify AFMESA at the above listed email address. Each RFI response will receive a confirmation email; if a confirmation is not received please call 301-619-8600. Please include a point of contact, phone number, e-mail address, website information, and indicate whether the company is a foreign or domestic entity in the contents of the e-mail. Responses must be received by this office on or before 2:00 (EST) on 5 February 2014. This RFI is not a commercial solicitation. The Government will not pay for any information submitted, or for any costs associated with providing the information. The response should describe the company's capability to offer, field, and sustain the vascular access device as characterized by the requirements addressed in this RFI. If unable to provide a vascular access device capable of meeting all requirements, the respondent should offer tradeoff considerations. 6. LATE SUBMISSIONS: Failure to respond to this RFI does not preclude participation in any future competition, nor will information provided in response to this RFI be used to exclude anyone from responding to any future requests for proposals. Communications with AFMESA in regard to this RFI will only be permitted in writing during the RFI response period. Responses to the RFI received by AFMESA after the submittal deadline and time indicated may be considered. The respondent assumes the risk of the method of dispatch chosen. Postmarking by the submittal date and time shall not substitute for actual response receipt. 7. OWNERSHIP OF RESPONSE TO RFI: All informational material submitted in response to this request becomes property of AFMESA. Physical samples will be returned to the vendor at the owner's expense. 8. RELEASE OF CLAIMS, LIABILITY, AND PREPARATION EXPENSES: Under no circumstances shall AFMESA be responsible for any response preparation expenses, submission costs, or any other expenses, costs, or damages of whatever nature incurred as a result of the respondent's participation in this RFI process. Respondent understands and agrees that they submit a response at their own risk and expense, and release AFMESA from any claim for damages or other liability arising out of the RFI process. 9. ERRORS IN RESPONSE: AFMESA shall not be liable for any errors in respondent's response. Respondent is responsible for careful review of its entire response to ensure that all information is correct and complete. Respondents are liable for all errors or omissions contained in their responses. 10. ADDENDUM: AFMESA reserves the right to issue an addendum to this RFI at any time for any reason. 11. CONTACT INFORMATION: Ms. Ashley A. Fredlock Air Force Medical Evaluation Support Activity (AFMESA) 1270 Montevue Lane (Area B) Fort Detrick, MD 21702 Phone: 301-619-8600 AFMSA.SG5T.Market@us.af.mil
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/notices/958932b014bb0ededa487125ca06831a)
 
Place of Performance
Address: Air Force Medical Evaluation Support Activity (AFMESA), 1270 Montevue Lane (Area B), Fort Detrick, Maryland, 21702, United States
Zip Code: 21702
 
Record
SN03261838-W 20140108/140106234451-958932b014bb0ededa487125ca06831a (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.